Date filters select awards with transaction activity in the period. Amounts below are lifetime award obligations. IDV values remain separate.
8511229452!ADENOVIRUS TYPE 4 ADepartment of Defense$165.2K obligationsEnds Mar 25, 2025
8511229453!ADENOVIRUS TYPE 4 ADepartment of Defense$165.2K obligationsEnds Mar 25, 2025
8511229455!ADENOVIRUS TYPE 4 ADepartment of Defense$165.2K obligationsEnds Mar 25, 2025
8511147946!ADENOVIRUS TYPE 4 ADepartment of Defense$5.3M obligationsEnds Feb 4, 2025
8511147948!ADENOVIRUS TYPE 4 ADepartment of Defense$330.3K obligationsEnds Feb 4, 2025
8511147949!ADENOVIRUS TYPE 4 ADepartment of Defense$660.6K obligationsEnds Feb 4, 2025
8511148052!ADENOVIRUS TYPE 4 ADepartment of Defense$1.2M obligationsEnds Feb 4, 2025
8511148053!ADENOVIRUS TYPE 4 ADepartment of Defense$165.2K obligationsEnds Feb 4, 2025
8511127239!ADENOVIRUS TYPE 4 ADepartment of Defense$0 obligationsEnds Jan 28, 2025
8511127463!ADENOVIRUS TYPE 4 ADepartment of Defense$0 obligationsEnds Jan 28, 2025
8511127468!ADENOVIRUS TYPE 4 ADepartment of Defense$0 obligationsEnds Jan 28, 2025
8511127473!ADENOVIRUS TYPE 4 ADepartment of Defense$0 obligationsEnds Jan 28, 2025
8511127474!ADENOVIRUS TYPE 4 ADepartment of Defense$0 obligationsEnds Jan 28, 2025
ADENOVIRUS VACCINE EFFICIENCY STUDY.Department of Defense$928.8K obligationsEnds Aug 4, 2021
8511030464!ADENOVIRUS TYPE 4 ADepartment of Defense$317.6K obligationsEnds Dec 3, 2024
8511009796!ADENOVIRUS TYPE 4 ADepartment of Defense$3.2M obligationsEnds Nov 19, 2024
8511009799!ADENOVIRUS TYPE 4 ADepartment of Defense$635.2K obligationsEnds Nov 19, 2024
8511009832!ADENOVIRUS TYPE 4 ADepartment of Defense$635.2K obligationsEnds Nov 19, 2024
8511009835!ADENOVIRUS TYPE 4 ADepartment of Defense$635.2K obligationsEnds Nov 19, 2024
8511009836!ADENOVIRUS TYPE 4 ADepartment of Defense$317.6K obligationsEnds Nov 19, 2024
8511009837!ADENOVIRUS TYPE 4 ADepartment of Defense$317.6K obligationsEnds Nov 19, 2024